Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 18 2013
Print RSS Feed

Breaking News

Related Searches:
Keata Pharma

August 18, 2008
Lou Panini has been named director, business development, Keata Pharma, Inc.  Mr. Panini has many years of experience in the pharmaceutical industry, having spent most of his career with Pfizer in Canada and Belgium. Mr. Panini began his career…  Read More »
WuXi AppTec

August 18, 2008
Garry Takle, Ph.D. has been appointed vice president of operations at WuXi AppTec, Inc., and Joseph Hughes, Ph.D. has been appointed vice president of testing services for the company's Philadelphia facility. Both Dr. Takle and Dr. Hughes will report…  Read More »
AMRI Begins Phase I Trial for Cancer Compound

August 18, 2008
AMRI initiated a Phase I study of ALB109564(a), a tubulin inhibitor designed to kill cancer cells by preventing cell mitosis. The study will be conducted at four trial sites for a period of nine to 12 months and will include as many as 40 subjects. T…  Read More »
Azopharma Adds To Clinical Research Services

August 15, 2008
Azopharma Product Development Group plans to expand its clinical research management services through its newly formed company, Acromon Clinical Research Organization. This company adds to the services provided by the human clinical dosing unit, Aviv…  Read More »
Onyx Pharmaceuticals

August 15, 2008
Dr. Juergen Lasowski has been appointed senior vice president of corporate development, Onyx Pharmaceuticals. In this role, Dr. Lasowski will lead business development activities for the company, assessing opportunities to potentially expand and dive…  Read More »
Meda Acquires Roche Products

August 15, 2008
Meda has reached an agreement with Roche to acquire four of its pharmaceutical products, strengthening its key therapy areas: cardiology, CNS and pain/inflammation. Meda acquired worldwide rights to the products, with the major markets including Germ…  Read More »
Abbott To Co-Promote AstraZeneca's Crestor

August 14, 2008
Abbott and AstraZeneca have entered into an agreement for Abbott to promote AZ's cholesterol drug Crestor. Under the terms of the agreement, Abbott will obtain the non-exclusive right to promote the drug alongside AZ in the U.S., excluding Puerto Ric…  Read More »
Tekmira, BMS Enter RNAi Research Pact

August 14, 2008
Tekmira Pharmaceuticals Corp. has entered into a research collaboration with Bristol-Myers Squibb using Tekmira's SNALP technology to deliver small interfering RNAs (siRNAs) to specific organs and tissues outside of the liver.     T…  Read More »
Stora Enso Signs Pharma DDS Partnerships

August 14, 2008
Stora Enso has signed the first Pharma DDS packaging license agreements in the U.S. and in Europe. The company will partner with Sharp Corp. to package pharmaceutical products into Pharma DDS cartons. An agreement has also been reached with Cadmus Wh…  Read More »
CSL To Acquire Talecris

August 13, 2008
CSL Ltd. has signed an agreement to acquire Talecris Biotherapeutics Holdings Corp. for $3.1 billion, enhancing its position in the global plasma market. Talecris produces plasma medicines in the U.S. and operates 56 plasma collection centers and two…  Read More »
Ricerca Biosciences

August 13, 2008
Desmond Cave has been named business development director in Europe for Ricerca Biosciences. Mr. Cave will be based in the UK and will focus on selling Ricerca’s discovery and preclinical services to the pharmaceutical and biotechnology industr…  Read More »
AAIPharma

August 13, 2008
Ronald Kershner has been appointed to lead AAIPharma's North American Biostatistics and Data Management Services groups. Mr. Kershner has more than 25 years of industry experience at several large pharmaceutical, biotechnology and contract research c…  Read More »
Schering-Plough Establishes Shanghai Operation

August 12, 2008
Schering-Plough has expanded its presence in China by establishing Shanghai Schering-Plough Pharmaceutical Co. Ltd. A wholly-owned operation based in Shanghai, the unit was formed through the acquisition of shares of its former joint venture partners…  Read More »
DSM To Manufacture Antibody for MorphoSys

August 12, 2008
DSM Biologics and MorphoSys AG signed a biopharmaceutical manufacturing agreement covering process development and cGMP manufacturing of MOR202, a fully human HuCAL antibody being studied for the treatment of multiple myeloma. DSM will manufacture MO…  Read More »
UCB Outsources Med-Chem Program to BioFocus DPI

August 12, 2008
BioFocus DPI, Galapagos' service division, has signed a contract with UCB to supply chemistry services in the UK for one of UCB's medicinal chemistry programs. The total contract value for Galapagos could potentially exceed $6 million. Galapagos is a…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: